Welcome to the official blog of Critical Outcome Technologies Inc. While we spend most of our time helping reduce the time, cost and risk of bringing new drugs to market, we use this space to provide more insight into the latest developments in our business as well as recent events in the field of drug discovery and development.
We invite you to join in the conversation and welcome your comments. We encourage you to visit our blog regularly and subscribe by RSS to ensure you receive updates as they occur. You may also choose to follow us on Facebook and Twitter for more frequent commentary.
About Critical Outcome Technologies Inc.
Critical Outcome Technologies Inc. is a biopharmaceutical company using machine learning to rapidly develop targeted therapies. Our proprietary artificial intelligence platform, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery through chemical optimization and preclinical testing. These compounds are targeted for a variety of diseases, particularly those for which current treatments are either lacking or ineffective.